PG
HALO icon

PEAK6 Group’s Halozyme HALO Stock Holding History

PEAK6 Group’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-11,390
Closed -$223K – 4547
2018
Q1 		$223K Buy
+11,390
New +$221K ﹤0.01% 3278

Other funds holding HALO

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PEAK6 Group's HALO Position: Q2 2018 in Review

PEAK6 Group sold out of Halozyme (HALO) in Q2 2018, closing a stake of 11,390 shares — an estimated $223K sold.

PEAK6 Group first reported a position in HALO in Q1 2018 and held it in 1 quarter. The position peaked at $223K in Q1 2018. 193 funds tracked by Wall St. Rank hold HALO as of Q2 2018.

  • PEAK6 Group reported no remaining Halozyme position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 11,390 Halozyme shares in Q2 2018, an estimated $223K.
  • PEAK6 Group first reported a position in Halozyme in Q1 2018 and held it in 1 quarter.
  • PEAK6 Group's Halozyme position peaked at $223K in Q1 2018.
  • 193 funds tracked by Wall St. Rank held Halozyme as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.